Cargando…
Drug Repositioning for Diabetes Based on 'Omics' Data Mining
Drug repositioning has shorter developmental time, lower cost and less safety risk than traditional drug development process. The current study aims to repurpose marketed drugs and clinical candidates for new indications in diabetes treatment by mining clinical ‘omics’ data. We analyzed data from ge...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422696/ https://www.ncbi.nlm.nih.gov/pubmed/25946000 http://dx.doi.org/10.1371/journal.pone.0126082 |